| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −2.5× | −1.7× | |
| Price / Book | 7.5× | 2.0× | |
| Price / Sales | 407.2× | 3.9× | |
| Price / Free cash flow | −16.1× | −1.5× | |
| EV / EBITDA | −2.4× | −1.2× | |
| Earnings yield | −39.6% | −14.3% | |
| Free cash flow yield | −6.2% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,286.00 | +3.68% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.56 | +2.27% | $625.51B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.16 | +2.29% | $510.98B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $420.81 | +3.42% | $377.72B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.09 | +3.11% | $365.36B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.50 | +2.19% | $282.97B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.65 | +2.87% | $261.56B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $689.11 | +1.43% | $254.8B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.07 | +2.38% | $235.21B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.36 | +2.15% | $193.88B | 22.3× | 37.5% | +29.9% |
